- Home
- NEXA vs QURE Comparison
NEXA vs QURE Comparison
Compare NEXA & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEXA
- QURE
- Stock Information
- Founded
- NEXA 1956
- QURE 1998
- Country
- NEXA Luxembourg
- QURE Netherlands
- Employees
- NEXA N/A
- QURE N/A
- Industry
- NEXA Metal Mining
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- NEXA Basic Materials
- QURE Health Care
- Exchange
- NEXA Nasdaq
- QURE Nasdaq
- Market Cap
- NEXA 660.9M
- QURE 725.4M
- IPO Year
- NEXA 2017
- QURE 2007
- Fundamental
- Price
- NEXA $4.68
- QURE $14.21
- Analyst Decision
- NEXA Sell
- QURE Strong Buy
- Analyst Count
- NEXA 3
- QURE 10
- Target Price
- NEXA $6.33
- QURE $37.20
- AVG Volume (30 Days)
- NEXA 35.8K
- QURE 1.2M
- Earning Date
- NEXA 07-31-2025
- QURE 07-31-2025
- Dividend Yield
- NEXA 2.15%
- QURE N/A
- EPS Growth
- NEXA N/A
- QURE N/A
- EPS
- NEXA N/A
- QURE N/A
- Revenue
- NEXA $2,813,814,000.00
- QURE $20,201,000.00
- Revenue This Year
- NEXA N/A
- QURE $27.16
- Revenue Next Year
- NEXA $3.43
- QURE $248.21
- P/E Ratio
- NEXA N/A
- QURE N/A
- Revenue Growth
- NEXA 13.20
- QURE 6.30
- 52 Week Low
- NEXA $4.64
- QURE $3.73
- 52 Week High
- NEXA $9.61
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- NEXA 30.66
- QURE 44.61
- Support Level
- NEXA $4.84
- QURE $14.75
- Resistance Level
- NEXA $5.00
- QURE $15.35
- Average True Range (ATR)
- NEXA 0.16
- QURE 1.05
- MACD
- NEXA 0.01
- QURE -0.27
- Stochastic Oscillator
- NEXA 7.84
- QURE 10.79
About NEXA Nexa Resources S.A.
Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.